Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Urine TMPRSS2:ERG Fusion Transcript Stratifies Prostate Cancer Risk in Men with Elevated Serum PSA
Authors
Keywords
-
Journal
Science Translational Medicine
Volume 3, Issue 94, Pages 94ra72-94ra72
Publisher
American Association for the Advancement of Science (AAAS)
Online
2011-08-04
DOI
10.1126/scitranslmed.3001970
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
- (2015) Kyung Park et al. NEOPLASIA
- Prostate cancer screening: current status and future perspectives
- (2010) Seth A. Strope et al. Nature Reviews Urology
- ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification
- (2010) B Furusato et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Development of Personalized Tumor Biomarkers Using Massively Parallel Sequencing
- (2010) R. J. Leary et al. Science Translational Medicine
- TMPRSS2:ERGfusion transcripts in urine from prostate cancer patients correlate with a less favorable prognosis
- (2009) KARI ROSTAD et al. APMIS
- Prostate cancer-derived urine exosomes: a novel approach to biomarkers for prostate cancer
- (2009) J Nilsson et al. BRITISH JOURNAL OF CANCER
- Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States
- (2009) J.-M. Mosquera et al. CLINICAL CANCER RESEARCH
- ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice
- (2009) Scott A. Tomlins et al. EUROPEAN UROLOGY
- Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
- (2009) G. Draisma et al. JNCI-Journal of the National Cancer Institute
- Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
- (2009) Bo Han et al. MODERN PATHOLOGY
- Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
- (2009) Jennifer C King et al. NATURE GENETICS
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
- (2009) Brett S Carver et al. NATURE GENETICS
- Mortality Results from a Randomized Prostate-Cancer Screening Trial
- (2009) Gerald L. Andriole et al. NEW ENGLAND JOURNAL OF MEDICINE
- Screening and Prostate-Cancer Mortality in a Randomized European Study
- (2009) Fritz H. Schröder et al. NEW ENGLAND JOURNAL OF MEDICINE
- ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells
- (2009) Y. Zong et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial
- (2008) Robert L. Grubb et al. BJU INTERNATIONAL
- Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer
- (2008) Nicolas B. Delongchamps et al. BJU INTERNATIONAL
- An updated catalog of prostate cancer predictive tools
- (2008) Shahrokh F. Shariat et al. CANCER
- Use of the Prostate-Specific Antigen Test among U.S. Men: Findings from the 2005 National Health Interview Survey
- (2008) L. E. Ross et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Pathologic Characteristics of Cancers Detected in the Prostate Cancer Prevention Trial: Implications for Prostate Cancer Detection and Chemoprevention
- (2008) M. S. Lucia et al. Cancer Prevention Research
- A First-Generation Multiplex Biomarker Analysis of Urine for the Early Detection of Prostate Cancer
- (2008) B. Laxman et al. CANCER RESEARCH
- Characterization of TMPRSS2-ERG Fusion High-Grade Prostatic Intraepithelial Neoplasia and Potential Clinical Implications
- (2008) J.-M. Mosquera et al. CLINICAL CANCER RESEARCH
- Screening for Prostate Cancer in 2008 II: The Importance of Molecular Subforms of Prostate-Specific Antigen and Tissue Kallikreins
- (2008) Flip H. Jansen et al. EUROPEAN UROLOGY
- Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
- (2008) Gerhardt Attard et al. JOURNAL OF CLINICAL ONCOLOGY
- Prostate Cancer Volume at Biopsy Predicts Clinically Significant Upgrading
- (2008) Fei Dong et al. JOURNAL OF UROLOGY
- PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome
- (2008) Ina L. Deras et al. JOURNAL OF UROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started